CHD4 and neoplasm: Low CHD4 mRNA expression was significantly associated with FIGO stage (stage I vs. stage III; p = 0.0018; stage I vs. stage IV; p = 0.0010; stage II vs. stage III; p = 0.0411; stage II vs. stage IV; p = 0.0321) and tumour grade (G; p = 0.0331) (Fig. 1B, C).